Navigation Links
Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
Date:9/17/2007

t

candidates;

-- the Company's assessment of its clinical trials;

-- the commencement and completion of clinical trials;

-- the Company's ability to develop, manufacture, license and sell its

products or product candidates;

-- the Company's ability to enter into and successfully execute license

and collaborative agreements, if any;

-- the adequacy of the Company's capital resources and cash flow

projections, and the Company's ability to obtain sufficient financing

to maintain the Company's planned operations;

-- the adequacy of the Company's patents and proprietary rights;

-- the impact of litigation that has been brought against the Company and

its officers and directors and any proposed settlement of such

litigation; and

-- the other risks described under Certain Risks and Uncertainties Related

to the Company's Business, as contained in the Company's Annual Report

on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2006 and its most recent quarterly report on Form 10-Q.

CONTACTS:

For Genta Incorporated

Tara Spiess

TS Communications Group, LLC

(908) 286-3980

info@genta.com


'/>"/>
SOURCE Genta Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
2. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
3. Malvern initiates European user group meetings for chemical imaging
4. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
5. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
6. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
7. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
8. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
9. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... 2013  The non-surgical Stretta® procedure ... energy is effective in control of gastroesophageal reflux ... for medication 10 years post-procedure, according to an ... Digestive Disease Week (DDW) meeting May 18-21, 2013 ... "The sustained improvement in GERD-HRQL scores ...
(Date:5/17/2013)... NEW YORK , May 17, 2013 ... of the most important ways in which mankind depends ... New York Botanical Garden,s multifaceted exhibition Wild Medicine: ... Italian Renaissance Garden, on view from May 18 ... http://photos.prnewswire.com/prnh/20130517/NY16603 ) The featured exhibition,s many attractions ...
(Date:5/17/2013)...  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... UBS Global Healthcare Conference in New York ... at 11 a.m. Eastern Time. To listen to the ... the Investor Relations section of the Company,s Web site at ... days after the event. About Orexigen® Therapeutics ...
Breaking Medicine Technology:Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2
... 2011 The association representing Montana,s providers of home ... in Congress to repeal the controversial Medicare "competitive" bidding ... "It is imperative that H.R. 1041 pass if ... patients and local businesses in Montana," said Mike Calcaterra, ...
... PARK, N.C., April 12, 2011 Max Neeman meets ... IV metabolic disorder trial across 1200 sites throughout India. ... multiple Phase IV studies for global sponsors with thousands ... across 1500 sites is currently in-process with four more ...
Cached Medicine Technology:Montana Medical Equipment Providers Back New Congressional Bill to Repeal Flawed Medicare Bidding Program 2Montana Medical Equipment Providers Back New Congressional Bill to Repeal Flawed Medicare Bidding Program 3Montana Medical Equipment Providers Back New Congressional Bill to Repeal Flawed Medicare Bidding Program 4Max Neeman International Completes Targeted Enrollment of 15,000 for Large Ph IV Study 2
(Date:5/19/2013)... 19, 2013 Daily Gossip reporters have subjected ... Cheat Foods That Burn Fat to a close analysis ... , The review is a detailed explanation of ... writer's recommendation. , The two nutritionists have discovered during their ... for the caloric intake and expenditure of our body, that ...
(Date:5/19/2013)... By Kathleen Doheny HealthDay Reporter , , ... supplements may help those with Crohn,s disease overcome ... the inflammatory bowel disease, according to new research. ... less physical, emotional and general fatigue, greater quality ... of daily living," said Tara Raftery, a research ...
(Date:5/19/2013)... People in Minnesota have a great option ... offering its 28 Day Fat Loss Formula. The best ... of their own home. The product sells for $135 dollars ... be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is ... now, but after using the 28 Day Fat Loss Formula ...
(Date:5/19/2013)... 19, 2013 Grinding your teeth at ... sleep, or annoying your spouse. At the same time, ... Central (“Snoring and Teeth Grinding Could Be a Sign ... grinding can be hard to prevent. Apparently, Obstructive Sleep ... one of its symptoms is a habit of teeth ...
(Date:5/19/2013)... Fat Burning Furnace developed by Rob Poulos ... with fat burning diet plans, training workouts, ... Furnace package, people will receive the Fat Burning Furnace ... The Fat Burning Furnace manual includes fat loss knowledge, ... mass. In addition, this book covers step-by-step instructions, techniques ...
Breaking Medicine News(10 mins):Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2
... , THURSDAY, Jan. 13 (HealthDay News) -- Scientists have ... to other chickens. This achievement could stop bird ... reduce the risk of bird flu epidemics that could ... the researchers at the Universities of Cambridge and Edinburgh ...
... THURSDAY, Jan. 13 (HealthDay News) -- Trying to fight the ... on making school lunches healthier. The new guidelines, from ... such changes in 15 years and include cutting salt and ... fare. "For the first time in a generation we ...
... Scientists have for the first time sequenced and ... in the gut of a premature newborn and ... Further studies involving more infants could eventually ... problems that afflict preemies, in particular the sometimes ...
... (Garrison, NY) Extra large private hospital rooms with plenty of ... new research shows that these and other architecture and design ... reduce health care expenses. They are among the elements of ... and analyzed by leaders in health care and design. Elements ...
... Mich. Surviving cancer may also mean surviving pain, according ... showing 20 percent of cancer survivors at least two years ... study, published online ahead of print in the American Cancer ... in cancer survivorship among the growing number of U.S. cancer ...
... HealthDay Reporter , THURSDAY, Jan. 13 (HealthDay News) -- This winter ... instead is turning out to be a more typical flu season, ... to get a flu shot, advice that seniors in particular should ... their age group the hardest, the experts added. The H1N1 flu ...
Cached Medicine News:Health News:U.S. Aims to Make School Lunches Healthier 2Health News:U.S. Aims to Make School Lunches Healthier 3Health News:Scientists sequence gut microbes of premature infant 2Health News:Scientists sequence gut microbes of premature infant 3Health News:Scientists sequence gut microbes of premature infant 4Health News:Scientists sequence gut microbes of premature infant 5Health News:Next-generation hospital design can improve health -- and save money 2Health News:Cancer survivors likely to experience pain at some point in care: U-M study shows 2Health News:Flu Season Looks Normal This Year, Experts Say 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: